Fundraising
Corsera Health
Corsera Health Raises $80M Series A | Once-Yearly Cardiovascular RNAi
Cambridge, MAJanuary 10, 20261 min read
Total Raised
$80M
Latest Round
Series A
Employees
40+
Corsera Health Closes $80M Series A
Corsera Health, developing once-yearly RNAi treatments for cardiovascular diseases, has raised $80 million in Series A funding.
Key Highlights
- Novel once-yearly dosing approach
- Focus on cardiovascular diseases
- RNAi therapeutic platform
Company Overview
Corsera Health is developing RNA interference therapeutics that require only once-yearly dosing, potentially transforming treatment adherence for chronic cardiovascular conditions.
Company Info
Headquarters
Cambridge, MA
Team Size
40+
Last Round
$80M(Jan 2026)
Investors (2)
O
OrbiMedLeadLead Investor
Healthcare investment firm
S
SofinnovaInvestor
Life sciences investor
Share
Related Reports
Fundraising
Tebra
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
SalesTools Research
Jan 11, 2026
0 min read•$200M
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free